<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1100">
 <label>220</label>
 <element-citation publication-type="journal" id="rf1090">
  <person-group person-group-type="author">
   <name>
    <surname>Camdessanche</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Morel</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pozzetto</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Paul</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tholance</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Botelho-Nevers</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>COVID-19 may induce Guillain-Barr√© syndrome</article-title>
  <source>Rev Neurol (Paris)</source>
  <volume>176</volume>
  <issue>6</issue>
  <year>2020 Jun</year>
  <fpage>516</fpage>
  <lpage>518</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neurol.2020.04.003</pub-id>
  <comment>S0035-3787(20)30522-1</comment>
  <pub-id pub-id-type="pmid">32334841</pub-id>
 </element-citation>
</ref>
